Cwm, LLC Chroma Dex Corp. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Cwm, LLC holds 94 shares of CDXC stock, worth $516. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$516

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$2.51 - $3.8 $235 - $357	94 New	94 $0
Q4 2018 Jan 25, 2019	BUY	$2.8 - $4.22 $56 - $84	20 New	20 $0
Q1 2018 Apr 26, 2018	SELL	$4.05 - $6.46 $4,050 - $6,460	-1,000 Closed	0 $0
Q4 2017 Jan 16, 2018	BUY	$3.88 - $6.96 $3,880 - $6,960	1,000	1,000 $6,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

Vanguard Group Inc Valley Forge, PA

3.43M
Shares

$18.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.12M
Shares

$17.1 Million
0.0% of portfolio
Tieton Capital Management, LLC Yakima, WA

2.96M
Shares

$16.2 Million
5.59% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.3M
Shares

$7.12 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

1.15M
Shares

$6.31 Million
0.0% of portfolio

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account